VIDENT INVESTMENT ADVISORY, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
VIDENT INVESTMENT ADVISORY, LLC portfolio value:
$5.79M
portfolio value
VIDENT INVESTMENT ADVISORY, LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -52.79% | -9.89K shares | -5.30M | $688.87 | 8.85K |
| Q2 2022 | share | Increase | +108.79% | 9.76K shares | 4.82M | $591.13 | 18.74K |
| Q1 2022 | share | Decrease | -34.04% | -4.63K shares | -2.32M | $698.42 | 8.97K |
| Q4 2021 | share | Decrease | -14.75% | -2.35K shares | -1.06M | $642.51 | 13.61K |
| Q3 2021 | share | Increase | +24.09% | 3.1K shares | 2.47M | $605.18 | 15.96K |
| Q2 2021 | share | Decrease | -11.30% | -1.64K shares | 324K | $558.54 | 12.86K |
| Q1 2021 | share | Increase | +49.97% | 4.83K shares | 2.19M | $473.14 | 14.50K |
| Q4 2020 | share | Increase | +17.19% | 1.41K shares | 51K | $483.11 | 9.67K |
| Q3 2020 | share | Increase | +6.35% | 493 shares | -219K | $559.78 | 8.25K |
| Q2 2020 | share | Increase | +0.13% | 10 shares | 1.05M | $623.65 | 7.76K |
| Q1 2020 | share | Increase | +73.19% | 3.27K shares | 2.10M | $488.29 | 7.75K |
| Q4 2019 | share | Decrease | -9.01% | -443 shares | 317K | $375.48 | 4.47K |
| Q3 2019 | share | Decrease | -3.32% | -169 shares | -229K | $277.4 | 4.91K |
| Q2 2019 | share | Increase | +14.78% | 655 shares | -227K | $313 | 5.08K |
| Q1 2019 | share | Decrease | -1.95% | -88 shares | 131K | $410.62 | 4.43K |
| Q4 2018 | share | Increase | +244.59% | 3.20K shares | 1.15M | $373.5 | 4.52K |
| Q3 2018 | share | Decrease | -23.45% | -402 shares | -61K | $404.04 | 1.31K |
| Q2 2018 | share | Decrease | -14.00% | -279 shares | -46K | $344.99 | 1.71K |
| Q1 2018 | share | Decrease | -8.07% | -175 shares | -178K | $344.36 | 1.99K |
| Q4 2017 | share | Increase | +383.93% | 1.72K shares | 615K | $375.96 | 2.16K |
| Q3 2017 | share | Increase | 0.00% | 448 shares | 200K | $447.12 | 448 |